MOUNTAIN VIEW, Calif., July 31, 2012 /PRNewswire/ -- Omnicell, Inc. (NASDAQ: OMCL), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced that nationally-ranked Hackensack University Medical Center (HackensackUMC), the largest provider of inpatient and outpatient services in New Jersey, selected Omnicell as its exclusive provider of automated medication management solutions throughout the 775-bed hospital. After an evaluation of competitive solutions, HackensackUMC selected Omnicell's G4 platform to improve pharmacy and nursing workflow and enhance overall patient safety. The hospital will also implement the Omnicell Anesthesia Workstation™ G4 in the operating rooms to automate processes for improving charge capture. (Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-a) (Logo: http://photos.prnewswire.com/prnh/20120731/SF48971LOGO-b) Committed to providing the most advanced patient care, HackensackUMC has been listed as the number one hospital in New Jersey and one of the top four New York metro area hospitals in the 2012-13 annual U.S. News & World Report Best Hospitals rankings, also receiving nine national rankings and four New York Metro Area rankings. It has also been recognized for six consecutive years as one of America's 50 Best Hospitals by HealthGrades. HackensackUMC's selection of Omnicell's G4 medication administration technology is the most recent example of its commitment to advanced medical care. Prior to its Omnicell investment, the hospital fully deployed an electronic health record and is currently implementing a bedside barcode administration system. HackensackUMC evaluated several vendors in a thorough process with collaboration of pharmacy, nursing, IT and radiology departments. HackensackUMC is a Magnet® recognized hospital for nursing excellence and it was important in the evaluation process to select solutions that nurses believe would improve workflows and increase patient satisfaction.
Since this summer's market low, small-cap stocks have been outperforming large-cap stocks. Here are small caps with 'persistently strong top-line growth and improving fundamentals,' according to RBC Capital Markets.